The effect of loading dose of magnesium sulfate on uterine, umbilical, and fetal middle cerebral arteries Doppler in women with severe preeclampsia: A case control study
This case control study included 100 pregnant women with severe pre-eclampsia. Umbilical artery, uterine artery, and fetal middle cerebral artery Doppler were measured before and 20 minutes after intravenous administration of 6 grams of magnesium sulfate.
Read More
A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia
The objectives of this research was to compare two methods of magnesium sulfate administration for duration of 12 hours, versus 24 hours after delivery in patients with severe pre-eclampsia.
Read More
Gaps and opportunities for pre-eclampsia and eclampsia care in Ethiopia
This brief shares findings from a study that explored the gaps in antenatal care in Ethiopia, with a focus on pre-eclampsia and eclampsia (PE/E) at national, health system, and community levels. The study took place in peri-urban and rural areas of the Southern Nations, Nationalities, and Peoples Region, and sought to understand the experience and burden of PE/E.
It specifically aimed to assess the policy and health systems environment related to PE/E diagnosis, referral, and treatment, and identified bottlenecks in the supply chain and investigated knowledge and perceptions of PE/E. It also aimed to describe barriers for provision/utilization of PE/E prevention and management, including antenatal and postnatal care during service delivery and within communities.
Read More
Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: a prospective observational cohort study in Norway
This population-based cohort study investigated whether the timing of probiotic milk consumption before, during early or late pregnancy influences pre-eclampsia and pre-term delivery.
Read More
Maternal serum bisphenol A levels and risk of pre-eclampsia: a nested case–control study
This study aimed to evaluate the relationship between maternal bisphenol A (BPA) exposure and the risk of pre-eclampsia. Recent studies have indicated the potential adverse effects of BPA exposure during pregnancy, such as an increased risk of pre-eclampsia, but epidemiological evidence is limited.
Read More
Blood Pressure Profile One Year After Severe Pre-eclampsia
This retrospective cohort study examined the prevalence of hypertension and 24-hour blood pressure (BP) patterns with ambulatory blood pressure monitoring (ABPM) in women one year after severe pre-eclampsia. Women included in the study were those referred to the Follow-Up Pre-Eclampsia Outpatient Clinic in Erasmus Medical Center, The Netherlands.
Read More
Feasibility of community level interventions for pre-eclampsia: perspectives, knowledge and task-sharing from Nigeria, Mozambique, Pakistan and India
This editorial discusses a supplement of seven studies that provide the results of the first round of the CLIP (Community Level Interventions for Pre-eclampsia) Feasibility Studies. These studies report a number of enablers and barriers in each setting and have informed the implementation of a cluster–randomized trial (cRCT), which is aimed at reducing pre-eclampsia-related, and all-cause, maternal and perinatal mortality and major morbidity using community-based identification and treatment of pre-eclampsia in selected geographies of Nigeria, Mozambique, Pakistan and India.
Effects of Lactation on Postpartum Blood Pressure Among Women with Gestational Hypertension and Pre-eclampsia
Women with a history of hypertensive disorders of pregnancy are at increased risk of hypertension and cardiovascular disease in later life. Lactation has been associated with reduced risk of maternal hypertension in the postpartum period and later life. However, little is known about whether lactation is also cardio-protective in women with hypertensive disorders of pregnancy such as pre-eclampsia or gestational hypertension.
Alternative regimens of magnesium sulfate for treatment of pre-eclampsia and eclampsia: a systematic review of non-randomized studies
The optimal dosing regimen of magnesium sulfate for treating pre-eclampsia and eclampsia is unclear. Evidence from the Cochrane review of randomized controlled trials (RCTs) was inconclusive due to lack of relevant data. To complement the evidence from the Cochrane review, we assessed available data from non-randomized studies on the comparative efficacy and safety of alternative magnesium sulfate regimens for the management of pre-eclampsia and eclampsia.
Maternal Mortality Predictors in Women With Hypertensive Disorders of Pregnancy: A Retrospective Cohort Study
Hypertensive disorders of pregnancy (HDP) are multisystem disorders unique to human pregnancy. They are becoming the leading causes of maternal mortality worldwide, with the majority of deaths occurring in low-income countries. However, little is known about the predictors of maternal mortality in women with HDP.
Read More
